ArticleLasers in medical science2026
Infrared low-level laser therapy enhances proliferation and viability in murine osteoblasts in vitro.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeInfrared low-level laser therapy (LLLT) has shown great promise in promoting cell proliferation and viability, making it a valuable tool in regenerative medicine. This study investigated how the interval between sessions shapes the response to 970 nm LLLT in murine osteoblast cultures by delivering three 10 J/cm² sessions separated by 24-48 h and measuring proliferation, reactive oxygen species (ROS), cytotoxicity, and apoptosis, with the goal of informing protocol design for bone regeneration.
methodsTwo osteoblast cultures were used, one control and the other LLL-treated group. The latter consisted of three irradiation sessions (10 J/cm
resultsThe experimental results showed a significant increase in cell proliferation after two and three sessions (p < 0.05), while ROS levels progressively accumulated, peaking after the third session (p < 0.001). Cell viability remained above 90% in both groups during the first 48 h; however, a slight but significant reduction was observed in the LLLT group at 96 h. Apoptosis levels were lower in LLLT-treated cells during early phases (24-48 h), suggesting a transient cytoprotective effect that diminished after the third session. These findings indicate that infrared LLLT promotes cell proliferation without inducing cytotoxicity or programmed cell death.
conclusionThe results demonstrate that applying three infrared LLLT sessions of 10 J/cm² applied at 24, 48, and 96 h promotes osteoblastic proliferation and viability without inducing cytotoxicity or apoptosis. The proposed protocol, defined by energy dose and irradiation timing, provides a safe and effective strategy for bone tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.